US Stock MarketDetailed Quotes

SABS SAB Biotherapeutics

Watchlist
  • 2.8450
  • +0.0050+0.18%
Close Jul 22 16:00 ET
  • 2.9900
  • +0.1450+5.10%
Post 16:25 ET
26.26MMarket Cap-423P/E (TTM)

SAB Biotherapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

SAB Biotherapeutics Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

--

Revenue(YoY)

944.58K

+62.55%
EPS(YoY)

-0.54

+63.01%
Analyst Rating

Buy

Jul 2, 2024

SAB Biotherapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
--2024/Q1944.580K / 0.000--
--2023/Q4305.010K / 0.000--
--2023/Q31.267M / 13.330K--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
--2024/Q1944.580K / 0.000--
--2023/Q4305.010K / 0.000--
--2023/Q31.267M / 13.330K--

Unlock Free Earnings Estimates

SAB Biotherapeutics Earnings Reports

  • 10-Q: Quarterly report

    May 20 16:06 ET

  • SAB Biotherapeutics | 10-K: Annual report

    Mar 29 13:23 ET

  • SAB Biotherapeutics: Q3 2023 Earnings Report

    Nov 13, 2023 16:48 ET

  • SAB Biotherapeutics | 10-Q: Q2 2023 Earnings Report

    Aug 21, 2023 08:23 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 2, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg